Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02574663
Title TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors TG Therapeutics, Inc.

gastroesophageal junction adenocarcinoma

colorectal adenocarcinoma

pancreatic adenocarcinoma

gastric adenocarcinoma

gastrointestinal stromal tumor


Gemcitabine + Nab-paclitaxel


Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab


Age Groups: adult
Covered Countries USA

No variant requirements are available.